Christopher Bunka - 29 Jul 2025 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
30 Jul 2025, 17:12:54 UTC
Prior SEC filing
16 May 2025
Next SEC filing
18 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/Chris Bunka/

Key filing fact

Christopher Bunka filed Form 4 for Lexaria Bioscience Corp. (LEXX) on 30 Jul 2025.

Key facts

  • This page summarizes Christopher Bunka's Form 4 filing for Lexaria Bioscience Corp. (LEXX).
  • 2 reported transactions and 7 derivative rows are listed below.
  • Accepted by SEC: 30 Jul 2025, 17:12.

Change

  • Previous filing in this sequence was filed on 16 May 2025.
  • Current net transaction value: +$25,241.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001103780 Primary reporting owner

BUNKA CHRISTOPHER

Relationship
Director
Address
SUITE 100, 740 MCCURDY ROAD, KELOWNA, BRITISH COLUMBIA, CANADA
Signature
/Chris Bunka/
Signature date
30 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LEXX transaction

common shares

Purchase

Transaction value
$14,375
Shares
+15,600
Change %
+6.1%
Price
$0.9215
Shares after
270,012
Date
29 Jul 2025
Ownership
Private Holding Company
LEXX transaction

common shares

Purchase

Transaction value
$10,866
Shares
+11,900
Change %
+4.4%
Price
$0.9131
Shares after
281,912
Date
30 Jul 2025
Ownership
Private Holding Company
LEXX holding

common shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
373,543
Date
29 Jul 2025
Ownership
Direct
LEXX holding

common shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
254,412
Date
29 Jul 2025
Ownership
Private Holding Company

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
26,000
Date
29 Jul 2025
Ownership
Direct
Underlying class
Common Shares
Underlying amount
26,000
Exercise price
$3.00
LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
49,334
Date
29 Jul 2025
Ownership
Direct
Underlying class
Common Shares
Underlying amount
23,334
Exercise price
$3.00
LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
64,334
Date
29 Jul 2025
Ownership
Direct
Underlying class
Common Shares
Underlying amount
15,000
Exercise price
$3.00
LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
94,334
Date
29 Jul 2025
Ownership
Direct
Underlying class
Common Shares
Underlying amount
30,000
Exercise price
$2.91
LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
124,334
Date
29 Jul 2025
Ownership
Direct
Underlying class
Common Shares
Underlying amount
30,000
Exercise price
$1.15
LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
173,834
Date
29 Jul 2025
Ownership
Direct
Underlying class
Common Shares
Underlying amount
49,500
Exercise price
$2.36
LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
184,834
Date
29 Jul 2025
Ownership
Direct
Underlying class
Common Shares
Underlying amount
11,000
Exercise price
$1.04
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .